Rehabilitation of Acquired Maxillary Defect With Patient-Specific Implants Post-mucormycosis Resection: A Case Report.

Publication date: Oct 01, 2024

The outbreak of COVID-19 swept massive masses causing rhinocerebral mucormycosis, a fatal mycotic infection, and high mortality among humans. ​It affects individuals with weakened immune systems, resulting in severe ulcers on the palate or perforation of the palate, accompanied by blackish necrotic tissue and exposure of underlying bone. ​ Some of the key symptoms include rhinorrhea, facial swelling, pain in the orofacial region, varying degrees of fever, headaches, blurred vision due to proptosis, and involvement of the contents of the orbit. The impairment is enormous and thus needs a surgical resection of the palate and associated structures, leaving the patient with both compromised function and psychological impairment. This case report presents a new digital technique for the rehabilitation of acquired maxillary defects with patient-specific implants.

Open Access PDF

Concepts Keywords
Bone defect
Mycotic maxillofacial prosthesis implantation
Psychological palatal obturator
Rhinorrhea patient-specific implant
Swept rhino-orbital mucormycosis

Semantics

Type Source Name
disease MESH mucormycosis
disease MESH COVID-19
disease MESH infection
disease MESH ulcers
disease MESH proptosis
disease MESH defects
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH complications
disease MESH morbidity
disease IDO site
disease MESH chronic pain
disease MESH gait
disease MESH necrosis
drug DRUGBANK Nonoxynol-9
disease MESH atrophy
disease IDO history
drug DRUGBANK Titanium
drug DRUGBANK Alginic acid
disease MESH psychological well being
drug DRUGBANK Cobalt
disease MESH tissue compatibility
disease MESH inflammation
disease MESH oral health
drug DRUGBANK Spinosad
drug DRUGBANK Honey

Original Article

(Visited 1 times, 1 visits today)